Blood Counts Recover to Normal Ranges After Neuroendocrine Tumor Radionuclide Therapy
A longitudinal study shows that hematologic reductions from lutetium-177 dotatate therapy in gastroenteropancreatic neuroendocrine tumor patients largely rebound into normal ...










